Polyamine  	Polyamine  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
for  	for  	 IN	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
feline  	feline  	 JJ	B-NP
oral  	oral  	 JJ	I-NP
squamous  	squamous  	 JJ	I-NP
cell  	cell  	 NN	I-NP
carcinoma 	carcinoma 	 NNS	I-NP
:  	:  	 :	O
a  	a  	 DT	O
proof-of-concept  	proof-of-concept  	 JJ	B-NP
study  	study  	 NN	I-NP
This  	This  	 DT	O
study  	study  	 NN	O
assessed  	assessed  	 VBD	B-NP
proof-of-concept  	proof-of-concept  	 JJ	I-NP
for  	for  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
polyamine  	polyamine  	 FW	O
inhibitor  	inhibitor  	 FW	O
2-diluoromethylornithine  	2-diluoromethylornithine  	 FW	O
( 	( 	 -LRB-	O
DFMO 	DFMO 	 NNP	B-NP
)  	)  	 -RRB-	O
as  	as  	 IN	O
a  	a  	 DT	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
oral  	oral  	 JJ	B-NP
squamous  	squamous  	 JJ	I-NP
cell  	cell  	 NN	I-NP
carcinoma  	carcinoma  	 NNS	I-NP
( 	( 	 -LRB-	O
SCC 	SCC 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
client-owned  	client-owned  	 JJ	O
cats 	cats 	 NNS	O
.  	.  	 .	O
Polyamine  	Polyamine  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
tumor  	tumor  	 NN	B-NP
tissue  	tissue  	 NN	I-NP
and  	and  	 CC	O
normal  	normal  	 JJ	B-NP
oral  	oral  	 JJ	I-NP
mucosa  	mucosa  	 NN	I-NP
were  	were  	 VBD	O
quantified  	quantified  	 VBN	O
before  	before  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
DFMO  	DFMO  	 NNP	B-NP
was  	was  	 VBD	O
administered  	administered  	 VBN	O
orally  	orally  	 VBN	O
to  	to  	 TO	O
14  	14  	 CD	O
client-owned  	client-owned  	 JJ	O
cats  	cats  	 NNS	O
with  	with  	 IN	O
histologically  	histologically  	 NN	O
confirmed  	confirmed  	 VBD	O
oral  	oral  	 JJ	B-NP
SCC 	SCC 	 NNP	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
monitored  	monitored  	 VBN	O
for  	for  	 IN	O
gastrointestinal 	gastrointestinal 	 NN	B-NP
,  	,  	 ,	O
dermatologic 	dermatologic 	 NN	B-NP
,  	,  	 ,	O
auditory 	auditory 	 NN	B-NP
,  	,  	 ,	O
hematological 	hematological 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
biochemical  	biochemical  	 JJ	B-NP
abnormalities 	abnormalities 	 NN	I-NP
.  	.  	 .	O
Total  	Total  	 JJ	B-NP
polyamine  	polyamine  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
tumor  	tumor  	 NN	B-NP
tissue  	tissue  	 NN	I-NP
decreased  	decreased  	 VBD	O
after  	after  	 IN	O
treatment 	treatment 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
did  	did  	 VBD	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
polyamine  	polyamine  	 JJ	B-NP
putrescine  	putrescine  	 NN	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
tumor  	tumor  	 NN	B-NP
tissue  	tissue  	 NN	I-NP
and  	and  	 CC	O
normal  	normal  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
Ototoxicity  	Ototoxicity  	 NNP	B-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
5  	5  	 CD	O
of  	of  	 IN	O
6  	6  	 CD	O
cats  	cats  	 NNS	O
receiving  	receiving  	 VBG	O
pre-  	pre-  	 JJ	O
and  	and  	 CC	O
post-treatment  	post-treatment  	 JJ	B-NP
brainstem  	brainstem  	 NNS	I-NP
auditory  	auditory  	 VBP	I-NP
evoked  	evoked  	 JJ	I-NP
potential  	potential  	 JJ	I-NP
tests 	tests 	 NNS	I-NP
.  	.  	 .	O
Subclinical  	Subclinical  	 JJ	B-NP
thrombocytopenia  	thrombocytopenia  	 NN	I-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
6  	6  	 CD	O
of  	of  	 IN	O
14  	14  	 CD	O
cats 	cats 	 NNS	O
.  	.  	 .	O
One  	One  	 CD	O
cat  	cat  	 NNS	O
showed  	showed  	 VBD	O
mild  	mild  	 JJ	O
post-anesthetic  	post-anesthetic  	 JJ	B-NP
tremors  	tremors  	 NNS	I-NP
that  	that  	 IN	O
resolved  	resolved  	 VBN	O
without  	without  	 IN	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Oral  	Oral  	 JJ	B-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	I-NP
DFMO  	DFMO  	 NNP	I-NP
at  	at  	 IN	O
doses  	doses  	 NNS	O
used  	used  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
significantly  	significantly  	 RB	O
decreased  	decreased  	 VBN	B-NP
tumor  	tumor  	 NN	I-NP
polyamine  	polyamine  	 NN	I-NP
levels  	levels  	 NNS	I-NP
without  	without  	 IN	O
life-threatening  	life-threatening  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
or  	or  	 CC	O
hematological  	hematological  	 JJ	B-NP
toxicities 	toxicities 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
warranted  	warranted  	 VBN	O
to  	to  	 TO	O
explore  	explore  	 VB	O
pathophysiology  	pathophysiology  	 VBN	O
of  	of  	 IN	O
polyamine  	polyamine  	 JJ	B-NP
biochemistry  	biochemistry  	 NN	I-NP
and  	and  	 CC	O
use  	use  	 NN	O
of  	of  	 IN	O
polyamine  	polyamine  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
in  	in  	 IN	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
cats  	cats  	 NNS	O
with  	with  	 IN	O
oral  	oral  	 JJ	B-NP
SCC 	SCC 	 NNP	I-NP
.  	.  	 .	O
